how are people getting retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country prescribing it anyway, a CBS News investigation Phase III retatrutide study demonstrates

maintaining these weight loss results presents significant challenges, as the majority of patients are expected to experience an 80% rebound in lost weight within five years

However, compulsive sexual behaviors increased in some users

Vogel, H

Prioritizing 7 to 9 hours of quality sleep each night supports the medications appetite-suppressing effects

Starting with lower doses and gradually increasing can help minimize these early symptoms

FuturHealth eliminates that barrier by offering GLP-1 semaglutide prescriptions without insurance, using a direct-to-consumer telehealth model that emphasizes convenience, affordability, and medical supervision